Christine E. Hallgreen

616 total citations
29 papers, 371 citations indexed

About

Christine E. Hallgreen is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christine E. Hallgreen has authored 29 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 10 papers in General Health Professions and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christine E. Hallgreen's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (8 papers) and Meta-analysis and systematic reviews (4 papers). Christine E. Hallgreen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (8 papers) and Meta-analysis and systematic reviews (4 papers). Christine E. Hallgreen collaborates with scholars based in Denmark, Netherlands and United States. Christine E. Hallgreen's co-authors include Kevin D. Hall, Marie L. De Bruin, Shahrul Mt‐Isa, Deborah Ashby, Lawrence D. Phillips, Alain Micaleff, Morten Colding‐Jørgensen, Richard Ofori‐Asenso, Torbjörn Callréus and Georgy Genov and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and International Journal of Obesity.

In The Last Decade

Christine E. Hallgreen

26 papers receiving 362 citations

Peers

Christine E. Hallgreen
Arun Bhatt United States
Nazleen F. Khan United States
Hsiang‐Wen Lin Taiwan
R Thiyagu India
Sieta T. de Vries Netherlands
Kimberly Westrich United States
Rosa Camila Lucchetta Brazil
Stephanie D. Schech United States
Adrian Hapca United Kingdom
Georgy Genov Netherlands
Arun Bhatt United States
Christine E. Hallgreen
Citations per year, relative to Christine E. Hallgreen Christine E. Hallgreen (= 1×) peers Arun Bhatt

Countries citing papers authored by Christine E. Hallgreen

Since Specialization
Citations

This map shows the geographic impact of Christine E. Hallgreen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. Hallgreen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. Hallgreen more than expected).

Fields of papers citing papers by Christine E. Hallgreen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. Hallgreen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. Hallgreen. The network helps show where Christine E. Hallgreen may publish in the future.

Co-authorship network of co-authors of Christine E. Hallgreen

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. Hallgreen. A scholar is included among the top collaborators of Christine E. Hallgreen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. Hallgreen. Christine E. Hallgreen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gräf, Débora Dalmas, et al.. (2025). Populations Addressed in Vaccines Approved via the European Medicines Agency. Clinical Pharmacology & Therapeutics. 118(2). 459–469.
2.
Gräf, Débora Dalmas, et al.. (2025). Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants. Drug Safety. 49(4). 493–503.
3.
4.
Zuidgeest, Mira G. P., Yared Santa‐Ana‐Téllez, Christine E. Hallgreen, et al.. (2025). The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice. Drug Discovery Today. 30(2). 104304–104304. 2 indexed citations
5.
Gräf, Débora Dalmas, et al.. (2024). The life cycle of vaccines evaluated by the European Medicines Agency. Vaccine. 42(21). 126186–126186. 1 indexed citations
6.
Hallgreen, Christine E., et al.. (2023). Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan. Biological and Pharmaceutical Bulletin. 46(5). 700–706. 2 indexed citations
7.
8.
Morrow, Richard L., Barbara Mintzes, Patrick C. Souverein, et al.. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety. 31(3). 179–190. 3 indexed citations
9.
Christiansen, Helle, Marie L. De Bruin, & Christine E. Hallgreen. (2022). Mandatory requirements for pediatric drug development in the EU and the US for novel drugs—A comparative study. Frontiers in Medicine. 9. 1009432–1009432. 2 indexed citations
10.
Christiansen, Helle, Marie L. De Bruin, Sven Frøkjær, & Christine E. Hallgreen. (2022). Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US. PLoS ONE. 17(4). e0266353–e0266353. 3 indexed citations
11.
Morrow, Richard L., Barbara Mintzes, Patrick C. Souverein, et al.. (2022). Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug Safety. 45(6). 623–638. 1 indexed citations
12.
Ofori‐Asenso, Richard, et al.. (2021). Impact of regulatory interventions to restrict the combined use of renin–angiotensin system blockers: A Danish nationwide drug utilisation study. British Journal of Clinical Pharmacology. 88(3). 1379–1384. 2 indexed citations
13.
Ofori‐Asenso, Richard, Christine E. Hallgreen, & Marie L. De Bruin. (2020). Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges. Frontiers in Medicine. 7. 582634–582634. 23 indexed citations
14.
15.
Kaae, Susanne, et al.. (2018). The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies. Research in Social and Administrative Pharmacy. 15(5). 475–482. 19 indexed citations
16.
Mt‐Isa, Shahrul, Edmond S. Chan, Gerald Downey, et al.. (2016). Recommendations for benefit–risk assessment methodologies and visual representations. Pharmacoepidemiology and Drug Safety. 25(3). 251–262. 56 indexed citations
17.
Aagaard, Lise, Christine E. Hallgreen, & Ebba Holme Hansen. (2016). Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance. International Journal of Obesity. 40(11). 1742–1747. 14 indexed citations
18.
Hallgreen, Christine E., Shahrul Mt‐Isa, A Lieftucht, et al.. (2015). Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Pharmacoepidemiology and Drug Safety. 25(3). 238–250. 18 indexed citations
19.
Hallgreen, Christine E., et al.. (2009). A Model of NEFA Dynamics with Focus on the Postprandial State. Annals of Biomedical Engineering. 37(9). 1897–1909. 26 indexed citations
20.
Hallgreen, Christine E. & Kevin D. Hall. (2007). Allometric relationship between changes of visceral fat and total fat mass. International Journal of Obesity. 32(5). 845–852. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Bhatt Breakdown of academic impact, for papers by Nazleen F. Khan Breakdown of academic impact, for papers by Hsiang‐Wen Lin Breakdown of academic impact, for papers by R Thiyagu Breakdown of academic impact, for papers by Sieta T. de Vries Breakdown of academic impact, for papers by Kimberly Westrich Breakdown of academic impact, for papers by Rosa Camila Lucchetta Breakdown of academic impact, for papers by Stephanie D. Schech Breakdown of academic impact, for papers by Adrian Hapca Breakdown of academic impact, for papers by Georgy Genov
Rankless by CCL
2026